Sugi Predict

Sugi Predict / Compounds / SCHEMBL19738484

SCHEMBL19738484

SCHEMBL19738484

c1ccc(N(c2ccc(-c3ccc4c5ccccc5n(-c5ccccc5)c4c3)cc2)c2ccc(N(c3ccccc3)c3ccc(-c4ccc5c6ccccc6n(-c6ccccc6)c5c4)cc3)cc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.55
▸ L3MBTL1 Q9Y468 3/20 0.55
▸ ATM Q13315 1/20 0.55
▸ HDAC4 P56524 1/20 0.39
▸ RXRA P19793 1/20 0.38
▸ RXRB P28702 1/20 0.38
▸ KMT2A Q03164 2/20 0.36
▸ MAPK8 P45983 2/20 0.36
▸ IL1R1 P14778 1/20 0.36
▸ TSPO P30536 1/20 0.36
▸ ALDH1A1 P00352 5/20 0.35
▸ MAPT P10636 3/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ CYP1A2 P05177 2/20 0.34
▸ CYP3A4 P08684 2/20 0.34
▸ CYP2C9 P11712 2/20 0.34
▸ CYP2C19 P33261 2/20 0.34
▸ CYP2D6 P10635 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19238794 1.00 KDM4E (0.55) KDM4EL3MBTL1ATMHDAC4RXRA
SCHEMBL19383180 1.00 KDM4E (0.55) KDM4EL3MBTL1ATMHDAC4RXRA
SCHEMBL19738442 1.00 KDM4E (0.55) KDM4EL3MBTL1ATMHDAC4RXRA
SCHEMBL19383060 1.00 KDM4E (0.55) KDM4EL3MBTL1ATMHDAC4RXRA
SCHEMBL13968739 0.98 KDM4E (0.53) KDM4EL3MBTL1ATMHDAC4RXRA
SCHEMBL13969291 0.98 KDM4E (0.53) KDM4EL3MBTL1ATMHDAC4RXRA
SCHEMBL13968737 0.98 KDM4E (0.53) KDM4EL3MBTL1ATMHDAC4RXRA
SCHEMBL13968685 0.98 KDM4E (0.53) KDM4EL3MBTL1ATMHDAC4RXRA
SCHEMBL19533762 0.98 KDM4E (0.53) KDM4EL3MBTL1ATMHDAC4RXRA
SCHEMBL13969294 0.98 KDM4E (0.53) KDM4EL3MBTL1ATMHDAC4RXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11233202-B2 Compound for organic electric element, organic electric element comprising the same and electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2022-01-25 — — US disclosed
US-20210226130-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2021-07-22 — — US disclosed
WO-2017217654-A1 COMPOUND FOR ORGANIC ELECTRONIC DEVICE, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC APPARATUS THEREOF 덕산네오룩스 주식회사 2017-12-21 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210226130-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF PIEZO1, OCIAD1, OR10J3 KDM4E 1104/4885L3MBTL1 915/4885ATM 4045/4885
US-11233202-B2 Compound for organic electric element, organic electric element comprising the same and electronic device thereof PIEZO1, OCIAD1, OR10J3 KDM4E 1104/4885L3MBTL1 915/4885ATM 4045/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.